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Abstract  
 
Large mysticete whales represent a unique challenge for chemical risk assessment. Few 
epidemiological investigations are possible due to the low incidence of adult stranding events. 
Similarly their often extreme life-history adaptations of prolonged migration and fasting 
challenge exposure assumptions. Molecular biomarkers offer the potential to complement 
information yielded through tissue chemical analysis, as well as providing evidence of a 
molecular response to chemical exposure. In this study we confirm the presence of cytochrome 
P450 reductase (CPR) and cytochrome P450 isoenzyme 1A1 (CYP1A1) in epidermal tissue of 
southern hemisphere humpback whales (Megaptera novaeangliae).  The detection of CYP1A1 in 
the integument of the humpback whale affords the opportunity for further quantitative non-
destructive investigations of enzyme activity as a function of chemical stress.  
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Introduction 
Persistent Organic Pollutants (POPs) are toxic anthropogenic chemicals and ubiquitous 
environmental contaminants. They are characterized by extremely long half-lives, 
bioaccumulation potential, and their capacity for undergoing Long Range Environmental 
Transport (LRET) hereby appearing in remote locations far from emission sources. POPs are 
subject to the Stockholm Convention, a legally binding treaty to ratifying nations that aims to 
reduce and ultimately eliminate sources of these chemicals to the environment (UNEP, 2002). 
The first generation of POPs originally listed under the convention were lipophilic, chlorinated 
aromatic compounds, such as organochlorine (OC) pesticides. Frequently semi-volatile, these 
legacy POPs are known to undergo fractionation along temperature gradients depositing out of 
the atmosphere at colder temperatures according to their volatility (Wania and Mackay, 1993). In 
this manner Polar Regions have been shown to act as environmental sinks for these compounds 
(Wania and Mackay, 1996). 
 
Although the adverse effects of OCs have been evidenced in controlled laboratory experiments 
on smaller mammals (e.g. Arzuaga et al., 2009; Ross et al., 1997; Song et al., 2010) elucidating 
the direct toxicological impact of contaminants in wildlife presents a greater challenge. Long-
lived cetaceans are often at the greatest risk of accumulating toxic levels of OCs and there is 
growing evidence that OC exposure plays a contributory role in a suite of adverse health effects 
including suppression of immune function (e.g. Lahvis et al., 1995), endocrine disruption (e.g. 
Brouwer et al., 1989; Reijnders, 1986), and cancer induction (e.g. Martineau et al., 2002). 
 
The 2010 International Whaling Commission (IWC) steering group on contaminants emphasized 
the need for directing research effort towards linking cetacean chemical exposure to individual or 
population level health effects to facilitate robust population based risk-assessments (IWC, 
2010).  Addressing this challenge must be facilitated through the optimum use of opportunistic 
stranding data combined with non-destructive investigations on free ranging animals.  Stranding 
data for large mysticetes, such as humpback whales, is extremely limited.  Unlike smaller species 
of cetaceans, particularly odontocetes, that may live-strand en mass (Brabyn et al., 1992; 
Mazzuca et al., 1999) humpback whales rarely live-strand (Willey et al., 1995).  Further, the 
carcass is often in an advanced state of decomposition and useful necropsies, disease 
identification, and collection of visceral organs is not feasible (Willey et al., 1995).  In view of 
the slow accumulation of data via stranding events, progress in mysticete toxicology must be 
underpinned by further advances in non-destructive methods combined with utilization and 
advancement of the molecular level investigations that such samples afford. 
 
The cytochrome P450 (CYP) enzyme system has evolved to both bioactivate  and metabolise 
endogenous and exogenous compounds (Bock and Kohle, 2009; Lewis et al., 1998).  Although 
CYP enzymes are most prevalent in the liver, studies have detected some CYP isozymes in a 
number of extra-hepatic tissues, including mammalian skin (Oesch et al., 2007; Yengi et al., 
2003).  The high specificity and inducibility of certain CYP isozymes for select chemical 
structures have facilitated their use as biomarkers of exposure and molecular level effects (Sarkar 
et al., 2006; Troisi and Mason, 1997). CYP1A1 is known to be inducible by planar OC 
compounds (Oritz De Montellano, 2005; Whitlock, 1999) and has been detected in the skin of all 
mammals investigated, including a number of cetacean species (Fossi et al., 2008; Hooker et al., 
2008; Oesch et al., 2007; Wilson et al., 2010; Yengi et al., 2003).  Specifically, CYP1A1 has 
been detected via immunohistochemistry in the integument of northern hemisphere humpback 
whales (Angell et al 2004).  CYP1A1 activity in cetacean skin has been correlated with blubber 
OC concentrations in a number of species, including e.g. fin whales (Balaenoptera physalus), 
striped dolphins (Stenella coeruleoalba) and Northern bottlenose whales (Hyperoodon 
ampullatus) (Fossi et al., 1992; Hooker et al., 2008; Marsili et al., 1998).  Recent advances in in 
vitro practices have confirmed the dose-dependent inducibility of CYP1A1 in sperm whale 
(Physeter macrocephalus) skin employing b-naphthoflavone (Godard et al., 2004).  In vitro 
CYP1A1 activation using OC inducers has further been performed using striped dolphin 
(Stenella coeruleoalba) and bottlenose dolphin (Tursiops truncatus) dolphin skin cultured 
fibroblasts (Fossi et al., 2008).  To date no peer-reviewed studies have investigated epidermal 
CYP activity or OC contaminant burdens of any southern hemisphere populations of humpback 
whales.   
 
This study investigated the presence of CYP1A1 protein, via western blotting, in the skin of 
southern hemisphere humpback whales to further facilitate toxicokinetic and toxicodynamic 
analyses. 
 
 
2. Methods 
2.1 Sample Collection 
Skin and blubber biopsies were obtained from humpback whales, of Breeding Stock E (as 
designated by the IWC) at two differing time points during their annual migration between 
2008 and 2009.  Sampling occurred in Moreton Bay Marine Park, North Stradbroke Island, 
South East Queensland, Australia (approx 27° 26 S, 153° 34 E; Fig. 1).   
 
All biopsies were obtained from a 6-metre rigid hull outboard vessel with a modified air rifle 
and flotation biopsy darts (Paxarms Ltd, New Zealand).  The biopsy dart tips had dimensions 
of 2.0 cm length and 0.7 cm diameter. Biopsies were collected from the dorsal region ventral 
and posterior to the dorsal fin, as recommended by Lambertsen et al. (1994).  Skin, for 
enzyme analysis, was snap frozen within 15 minutes of collection and later stored at -80°C 
until time of analysis.  Skin sub-samples for genetic determination were maintained on ice 
and later stored in Dimethyl sulfoxide (DMSO, ≥99.9%, Sigma-Aldrich) at -20o C until time 
of analysis.   
 
2.2 Sex Determination 
Sex determination of individual animals was carried out at the Australian Marine Mammal 
Centre (AMMC) using a 5’ exonuclease assay of the polymorphisms in the sex-linked Zinc 
Finger genes (Morin et al., 2005).  
 
2.3 Study animals  
Five free-swimming humpback whales (3 males and 2 females), from both northward and 
southward migration sampling events were selected for the current study (Table 1).   
 
2.4 Preparation of extra-hepatic microsomes 
Isolation of microsomal fractions from humpback whale integument was performed briefly as 
follows. The skin sample was homogenized by freezing in liquid nitrogen and pulverizing 3-4 
times with a ceramic mortar and pestle in a Tris-acetate buffer (pH 7.4) (White et al., 1994).  
Igepal (10%) was added to the homogenate to aid in the chemical breakdown and the 
homogenate was centrifuged at 12 000 x g for 20 minutes at 4°C, and again at 100 000 × g for 60 
minutes at 4°C.  The pellet was re-suspended in Tris-acetate buffer (pH 7.4) and stored at -80°C 
until biochemical analysis.  Protein concentration was determined using the method of Lowry et 
al. (1951) with bovine serum albumin (BSA) as the reference standard.  The amount of tissue 
(wet weight) collected by biopsy ranged from 0.27-0.42 g.  These quantities were sufficient for 
determination of CYP expression by western blot analysis with protein yields ranging between 
1.55-2.68 mg/g skin. 
 
2.5 Western Blotting 
NADPH-CYP reductase (CPR) and the isozyme CYP1A1 were characterized by western 
blotting.  Primary polyclonal antibodies for CPR and CYP1A1 respectively were α-rabbit anti-
cytochrome P450 reductase (Stressgen Bioreagents) and α-rabbit CYP1A1 antibody (Abcam), 
with HRP linked goat-α-rabbit secondary polyclonal antibody (Abcam).  Molecular weight 
markers were obtained from Biorad (precision plus protein dual standard).  Each well of a 
NuPAGE 10% Bis-tris gel contained 10 µg of microsomal protein of each sample and were 
separated at 120 V for 1.5 hours at room temperature before being transferred to a nitrocellulose 
membrane at 90 V for one hour at 4°C.  The membrane was then blocked for 1.5 hours in 1% 
skim milk in TBS (pH 7.5) and incubated with primary antibody (1:1000) for one hour.  The 
membrane was vigorously rinsed in TBST, before being incubated with secondary antibody for 
one hour (1:3500).  After further vigorous rinsing in TBST the bands were visualized via 
chemiluminescent detection (Amersham ECL plus, GE healthcare), on Fuji Medical X-ray Film 
(Imaging Solutions, QLD).  The blots were performed in duplicate with positive controls for 
CPR and CYP1A1 of NADPH-cytochrome P450 reductase protein of natural rat (Stressgen 
Bioreagents) and Aroclor 1254 induced rat liver microsomes, (CYP1A1; Moltox). 
 
3. Results and Discussion 
The existence of the CYP system in humpback whale skin was verified in a test sample by 
the immunochemical presence of the CYP reductase system (CPR). Subsequently CYP1A1 
was probed for and detected in five individual whales selected for this study (Fig. 2). 
 
CYP1A1 was present in both genders and in individuals on both the northward and 
southward legs of the migration journey. The protein concentration in the immunoblot of 
each individual whale was maintained constant (10 µg) hence the thickness of each band is a 
semi-quantitative indication of the level of induction of CYP1A1.  A high level of inter-
individual variability was observed in the level in the induction of CYP1A1 between the five 
individuals. This is anticipated as internal factors, such as genetics, age, and gender, 
combined with external environmental factors are thought to significantly influence CYP1A 
expression (Ho et al., 2007; Lin et al., 2003; Smart and Daly, 2000; Sy et al., 2001).  As these 
findings are not coupled with detailed information regarding individual-specific internal or 
external factors, no comprehensive discussion of the individual expressions can be made. Of 
notable interest however is the observation that the two female individuals appear to have the 
lowest levels of CYP1A1 protein (Fig 2; Whale 3 & 5).  This observation is congruent with 
expected contaminant burdens of females of reproductive age compared to males within 
same age category.  Reproductive females expend large amounts of energy through 
parturition and lactation thereby effectively transferring lipid energy stores and associated 
OC burdens to their young (Aguilar and Borrell, 1994; Debier et al., 2003). 
   
To date there is no peer-reviewed literature on OC contaminant burdens of southern 
hemisphere humpback whales and as previously discussed toxicological and epidemiological 
data is also lacking. Although lower trophic level mysticetes are less susceptible to 
accumulation of toxic OC burdens compared to odontocete counterparts, their extreme life-
history adaptation of simultaneous fasting, migration and reproduction potentially places 
them in an elevated risk category through seasonal re-mobilisation of accumulated OC 
burdens. Quantification of CYP1A1 activity will provide, at minimum, a biologically 
relevant complementary measure to chemical analysis, and at best an early biological effect 
of exposure to contaminant inducers, facilitating the scope for improved chemical risk 
assessments for the species.  
 
Conclusion 
This study provides the first evidence of CPR in southern hemisphere humpback whale 
integument and verifies the presence of CYP1A1 enzyme protein, hereby expanding the 
repertoire of biochemical assessments possible on the species via non-destructive methods.  The 
CYP1A1 protein was expressed in both genders, including a lactating female, and at both 
migration time points.  The findings represent a quality assurance step in ongoing studies of 
enzyme activity as a function of subcutaneous blubber OC concentration.    
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Figure and Table Captions 
Fig. 1. The geographical location of study sampling site; North Stradbroke Island, Queensland, 
Australia 
 
Table 1. Migration status, sex, estimated age class, and pod composition. 
 
  
Fig. 2. The above Western Blot (WB) shows the presence of CYP1A1 in the skin of 5 individual, 
humpback whales.  Arrowhead indicates expected molecular size of CYP1A1 (57KDa). *= purified 
rat liver microsome CYP1A1, which was included on the blots as a positive control. 
 
 
 
 
